Literature DB >> 21449009

LRRK2 G2019S mutations may be increased in Puerto Ricans.

Rachel Saunders-Pullman, Jose Cabassa, Marta San Luciano, Kaili Stanley, Deborah Raymond, Laurie J Ozelius, Susan B Bressman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21449009      PMCID： PMC3140626          DOI： 10.1002/mds.23632

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  7 in total

1.  Low frequency of common LRRK2 mutations in Mexican patients with Parkinson's disease.

Authors:  Petra Yescas; Marisol López; Nancy Monroy; Marie-Catherine Boll; Mayela Rodríguez-Violante; Ulises Rodríguez; Adriana Ochoa; María Elisa Alonso
Journal:  Neurosci Lett       Date:  2010-08-18       Impact factor: 3.046

2.  LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.

Authors:  Laurie J Ozelius; Geetha Senthil; Rachel Saunders-Pullman; Erin Ohmann; Amanda Deligtisch; Michele Tagliati; Ann L Hunt; Christine Klein; Brian Henick; Susan M Hailpern; Richard B Lipton; Jeannie Soto-Valencia; Neil Risch; Susan B Bressman
Journal:  N Engl J Med       Date:  2006-01-26       Impact factor: 91.245

3.  Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain.

Authors:  María C González-Fernández; Elena Lezcano; Owen A Ross; Juan C Gómez-Esteban; Fernando Gómez-Busto; Fernando Velasco; Maite Alvarez-Alvarez; María B Rodríguez-Martínez; Roberto Ciordia; Juan J Zarranz; Matthew J Farrer; Ignacio F Mata; Marian M de Pancorbo
Journal:  Parkinsonism Relat Disord       Date:  2007-05-30       Impact factor: 4.891

4.  Recent genetic selection in the ancestral admixture of Puerto Ricans.

Authors:  Hua Tang; Shweta Choudhry; Rui Mei; Martin Morgan; William Rodriguez-Cintron; Esteban González Burchard; Neil J Risch
Journal:  Am J Hum Genet       Date:  2007-08-01       Impact factor: 11.025

5.  Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study.

Authors:  Roy N Alcalay; Elise Caccappolo; Helen Mejia-Santana; Ming Xin Tang; Llency Rosado; Barbara M Ross; Miguel Verbitsky; Sergey Kisselev; Elan D Louis; Cynthia Comella; Amy Colcher; Danna Jennings; Martha A Nance; Susan B Bressman; William K Scott; Caroline Tanner; Susan Mickel; Howard Andrews; Cheryl Waters; Stanley Fahn; Lucien Cote; Steven Frucht; Blair Ford; Michael Rezak; Kevin Novak; Joseph H Friedman; Ronald Pfeiffer; Laura Marsh; Bradley Hiner; Andrew Siderowf; Ruth Ottman; Karen Marder; Lorraine N Clark
Journal:  Arch Neurol       Date:  2010-09

6.  Familial aggregation of Parkinson's disease in a multiethnic community-based case-control study.

Authors:  Michael Y Shino; Valerie McGuire; Stephen K Van Den Eeden; Caroline M Tanner; Rita Popat; Amethyst Leimpeter; Allan L Bernstein; Lorene M Nelson
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

7.  Genetic analysis of LRRK2 mutations in patients with Parkinson disease.

Authors:  Hao Deng; WeiDong Le; Yi Guo; Christine B Hunter; WenJie Xie; MaoSheng Huang; Joseph Jankovic
Journal:  J Neurol Sci       Date:  2006-11-09       Impact factor: 3.181
  7 in total
  1 in total

1.  Novel Variants in LRRK2 and GBA Identified in Latino Parkinson Disease Cohort Enriched for Caribbean Origin.

Authors:  Karen Nuytemans; Farid Rajabli; Parker L Bussies; Katrina Celis; William K Scott; Carlos Singer; Corneliu C Luca; Angel Vinuela; Margaret A Pericak-Vance; Jeff M Vance
Journal:  Front Neurol       Date:  2020-11-12       Impact factor: 4.003
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.